Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chalid Assaf

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Investigative Dermatology|July 18, 2008
Dominance of nonmalignant T-cell clones and distortion of the TCR repertoire in the peripheral blood of patients with cutaneous CD30+ lymphoproliferative disordersDaniel Humme, Ansgar Lukowsky, Matthias Steinhoff, et al.
The British Journal of Dermatology|January 23, 2023
Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphomaMathias Oymanns, Michael Daum-Marzian, Aliyah Bellm, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
Versorgungsstruktur der Patienten mit Mycosis fungoides und Sézary-Syndrom in Deutschland - Versorgungsforschung auf Basis von GKV-RoutinedatenChalid Assaf, Gabor Dobos, Immo-Maximilian Zech, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 26, 2022
Bendamustine monochemotherapy in aggressive or advanced-stage primary cutaneous T-cell lymphomasAlena-Lioba Michalowitz, Sven-Niklas Burmann, Frank Oellig, et al.
Leukemia Research|August 2, 2008
Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndromeMatthias Steinhoff, Sebastian Schöpp, Chalid Assaf, et al.
Journal of the American Academy of Dermatology|January 31, 2012
Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placeboH Miles Prince, Madeleine Duvic, Ann Martin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 2, 2022
Care structure of patients with mycosis fungoides and Sézary syndrome in Germany - Care research based on SHI claims dataChalid Assaf, Gabor Dobos, Immo-Maximilian Zech, et al.
Open Forum Infectious Diseases|November 2, 2020
Cutaneous Vasculitis in a Patient With COVID-19Katrin Kösters, Sitha Schwarzer, Achim Labuhn, et al.
JAMA Dermatology|June 26, 2020
Bendamustine Monotherapy for Primary Cutaneous Gamma-Delta T-Cell LymphomaAlexander Kreuter, Bijan Koushk-Jalali, Georgios Mitrakos, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Cutaneous lymphomasRudolf Stadler, Chalid Assaf, Claus-Detlev Klemke, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Investigative Dermatology|July 18, 2008
Dominance of nonmalignant T-cell clones and distortion of the TCR repertoire in the peripheral blood of patients with cutaneous CD30+ lymphoproliferative disordersDaniel Humme, Ansgar Lukowsky, Matthias Steinhoff, et al.
The British Journal of Dermatology|January 23, 2023
Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphomaMathias Oymanns, Michael Daum-Marzian, Aliyah Bellm, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
Versorgungsstruktur der Patienten mit Mycosis fungoides und Sézary-Syndrom in Deutschland - Versorgungsforschung auf Basis von GKV-RoutinedatenChalid Assaf, Gabor Dobos, Immo-Maximilian Zech, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 26, 2022
Bendamustine monochemotherapy in aggressive or advanced-stage primary cutaneous T-cell lymphomasAlena-Lioba Michalowitz, Sven-Niklas Burmann, Frank Oellig, et al.
Leukemia Research|August 2, 2008
Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndromeMatthias Steinhoff, Sebastian Schöpp, Chalid Assaf, et al.
Journal of the American Academy of Dermatology|January 31, 2012
Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placeboH Miles Prince, Madeleine Duvic, Ann Martin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 2, 2022
Care structure of patients with mycosis fungoides and Sézary syndrome in Germany - Care research based on SHI claims dataChalid Assaf, Gabor Dobos, Immo-Maximilian Zech, et al.
Open Forum Infectious Diseases|November 2, 2020
Cutaneous Vasculitis in a Patient With COVID-19Katrin Kösters, Sitha Schwarzer, Achim Labuhn, et al.
JAMA Dermatology|June 26, 2020
Bendamustine Monotherapy for Primary Cutaneous Gamma-Delta T-Cell LymphomaAlexander Kreuter, Bijan Koushk-Jalali, Georgios Mitrakos, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Cutaneous lymphomasRudolf Stadler, Chalid Assaf, Claus-Detlev Klemke, et al.
Pageof 13